Results 111 to 120 of about 5,945,207 (220)
We have quantified specific [3H]-ouabain binding sites in normal human lymphocytes, and have measured the changes in the numbers of those sites which occur in response to various stimuli.
Harper, C +4 more
core +1 more source
Ethacrynic acid is a broad acting glutathione transferase inhibitor, and its incorporation within suitable metal complexes results in enhancement of the anticancer activity.1 A series of pyridine- and phosphine-based ligands functionalized with ...
Biancalana, L. +18 more
core
Isolated frog muscles were exposed to concentrations of ethacrynic acid (2,3-dichloro-4-(2-methylene-butyryl)phenoxyaceticacid)ranging from 10−8 to 10−2 M.
T. S. Still +3 more
core +1 more source
Synthesis and Cytotoxic Activity of Ruthenium Complexes with Ethacrynic Acid Derived Ligands
There is currently high interest in the design of organic motifs containing biologically-active fragments to be incorporated within suitable metal complexes, in order to confer them enhanced anticancer activity. One of the possible approaches regards the
Biancalana, L. +13 more
core
Effects of trifluoperazine, ouabain, and ethacrynic acid on intestinal calcium transport
Bidirectional steady-state calcium fluxes were measured in vitro under short-circuited conditions in segments of rat duodenum and descending colon. The calcium-activated ATPase (Ca-ATPase) inhibitor trifluoperazine (TFP, 0.1 mM) reduced net calcium ...
E. Angeid-Backman +3 more
core +1 more source
The glutathione S-transferase (GST) activity towards 1-chloro-2,4-dinitrobenzene in intact human IGR-39 melanoma cells was determined by the quantification by HPLC-analysis of the excreted glutathione (GSH) conjugate (S-(2,4-dinitrophenyl)glutathione ...
Bladeren, P.J. van +6 more
core
Pyridine- and phosphine-based ligands modified with ethacrynic acid (EA, i.e. a broad acting glutathione transferase inhibitor) were prepared and coordinated to ruthenium(II)-arene complexes.1 All the compounds (ligands and complexes) were fully ...
Biancalana, L. +18 more
core
Bromocriptine-associated ototoxicity
Three patients treated with bromocriptine for chronic hepatic encephalopathy showed audiometric evidence of bilateral sensori-neural hearing-loss. Audiometrically, the hearing improved in all three patients when the bromocriptine dosage was reduced, thus
Morgan, MY, Ballantyne, J, Lanthier, PL
core

